Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Optimi Health Corp. - Common Shares (NQ:OPTH)

4.950 -0.010 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,184
Open 4.990
Bid (Size) 4.450 (200)
Ask (Size) 5.850 (100)
Prev. Close 4.960
Today's Range 4.730 - 5.000
52wk Range 4.000 - 6.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioMedNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 3 MDMA-Assisted Therapy Trial for PTSD
Via Investor Brand Network
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Plans Phase 2 Psilocybin Trial for Major Depressive Disorder
Via Investor Brand Network

Performance

YTD
-18.6%
-18.6%
1 Month
+4.7%
+4.7%
3 Month
+16.7%
+16.7%
6 Month
-18.6%
-18.6%
1 Year
-18.6%
-18.6%

More News

Read More
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes First Psilocybin Export to United Kingdom for Planned Phase 2 Trial
Via Investor Brand Network
Topics Supply Chain
News headline image
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
From OPTIMI HEALTH CORP.
Via GlobeNewswire
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Advances Ibogaine Drug Development Program
Via Investor Brand Network
News headline image
Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development
From OPTIMI HEALTH CORP.
Via GlobeNewswire
BioMedNewsBreaks — Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Completes GMP Production Run of 5mg Psilocybin Drug Product
Via Investor Brand Network
News headline image
Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia
From OPTIMI HEALTH CORP.
Via GlobeNewswire
NetworkNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update
Via Investor Brand Network
News headline image
Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
From OPTIMI HEALTH CORP.
Via GlobeNewswire
PsychedelicNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Featured in Diamond Equity Research Initiation Report Highlighting Commercial Psychedelics Opportunity
Via Investor Brand Network
InvestorNewsBreaks – Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) Prices $15 Million Public Offering in Connection With Nasdaq Uplisting
Via Investor Brand Network
News headline image
Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
Via PressReach
Topics Regulatory Compliance

Frequently Asked Questions

Is Optimi Health Corp. - Common Shares publicly traded?
Yes, Optimi Health Corp. - Common Shares is publicly traded.
What exchange does Optimi Health Corp. - Common Shares trade on?
Optimi Health Corp. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Optimi Health Corp. - Common Shares?
The ticker symbol for Optimi Health Corp. - Common Shares is OPTH on the Nasdaq Stock Market
What is the current price of Optimi Health Corp. - Common Shares?
The current price of Optimi Health Corp. - Common Shares is 4.950
When was Optimi Health Corp. - Common Shares last traded?
The last trade of Optimi Health Corp. - Common Shares was at 09/18/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.